Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
Background This study aims to identify the causative strain of SARS-CoV-2 in a cluster of
vaccine breakthroughs. Vaccine breakthrough by a highly transmissible SARS-CoV-2 strain …
vaccine breakthroughs. Vaccine breakthrough by a highly transmissible SARS-CoV-2 strain …
[HTML][HTML] Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021
S Alizon, S Haim-Boukobza, V Foulongne… - …, 2021 - eurosurveillance.org
We analysed 9,030 variant-specific RT-PCR tests performed on SARS-CoV-2-positive
samples collected in France between 31 May and 21 June 2021. This analysis revealed …
samples collected in France between 31 May and 21 June 2021. This analysis revealed …
Humoral immune response after different SARS-CoV-2 vaccination regimens
R Rose, F Neumann, O Grobe, T Lorentz… - BMC medicine, 2022 - Springer
Background The humoral immune response after primary immunisation with a SARS-CoV-2
vector vaccine (AstraZeneca AZD1222, ChAdOx1 nCoV-19, Vaxzevria) followed by an …
vector vaccine (AstraZeneca AZD1222, ChAdOx1 nCoV-19, Vaxzevria) followed by an …
[HTML][HTML] Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo olympic games, Japan, July 2021
Using numbers of SARS-CoV-2 variants detected in Japan as at 13 June 2021, relative
instantaneous reproduction numbers (RRI) of the R. 1, Alpha, and Delta variants with …
instantaneous reproduction numbers (RRI) of the R. 1, Alpha, and Delta variants with …
Interferon resistance of emerging SARS-CoV-2 variants
K Guo, BS Barrett, JH Morrison… - Proceedings of the …, 2022 - National Acad Sciences
The emergence of SARS-CoV-2 variants with enhanced transmissibility, pathogenesis, and
resistance to vaccines presents urgent challenges for curbing the COVID-19 pandemic …
resistance to vaccines presents urgent challenges for curbing the COVID-19 pandemic …
2023/24 mid-season influenza and Omicron XBB. 1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)
DM Skowronski, Y Zhan, SE Kaweski… - …, 2024 - eurosurveillance.org
The Canadian Sentinel Practitioner Surveillance Network reports mid-season 2023/24
influenza vaccine effectiveness (VE) of 63%(95% CI: 51–72) against influenza A (H1N1) …
influenza vaccine effectiveness (VE) of 63%(95% CI: 51–72) against influenza A (H1N1) …
CLIMB-COVID: continuous integration supporting decentralised sequencing for SARS-CoV-2 genomic surveillance
In response to the ongoing SARS-CoV-2 pandemic in the UK, the COVID-19 Genomics UK
(COG-UK) consortium was formed to rapidly sequence SARS-CoV-2 genomes as part of a …
(COG-UK) consortium was formed to rapidly sequence SARS-CoV-2 genomes as part of a …
Detecting SARS-CoV-2 variants with SNP genoty**
Tracking genetic variations from positive SARS-CoV-2 samples yields crucial information
about the number of variants circulating in an outbreak and the possible lines of …
about the number of variants circulating in an outbreak and the possible lines of …
[HTML][HTML] SARS-CoV-2 variants reveal features critical for replication in primary human cells
MO Pohl, I Busnadiego, V Kufner, I Glas, U Karakus… - PLoS …, 2021 - journals.plos.org
Since entering the human population, Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2; the causative agent of Coronavirus Disease 2019 [COVID-19]) has spread …
(SARS-CoV-2; the causative agent of Coronavirus Disease 2019 [COVID-19]) has spread …
[HTML][HTML] COVID-19 outbreak caused by contaminated packaging of imported cold-chain products—Liaoning Province, China, July 2020
H Ma, J Zhang, J Wang, Y Qin, C Chen, Y Song… - China CDC …, 2021 - ncbi.nlm.nih.gov
Few major outbreaks of coronavirus disease 2019 (COVID-19) have occurred in China after
major nonpharmaceutical interventions and vaccines have been deployed and …
major nonpharmaceutical interventions and vaccines have been deployed and …